Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
220020453 220006196 1.63 58.3 Curative (C) 2016-07-09 2016-07-11 AML 19 TRIAL N N 220023499 AML19 TRIAL
220020454 220019485 1.72 72 Curative (C) 2017-12-30 2018-02-07 AML 19 TRIAL Y N 220023564 AML19 TRIAL
220020456 220006215 1.68 68.3 Curative (C) 2015-12-23 2016-03-17 AML 19 TRIAL Y N 220023606 AML19 TRIAL
220020457 220006222 1.72 67.8 Curative (C) 2017-05-25 2017-08-07 AML 19 TRIAL N N 220023625 AML19 TRIAL
220020458 220006226 null 95.7 Palliative (P) 2015-05-08 2015-08-21 Trial Unspecified N N 220023640 TRIAL
220020459 220006229 1.81 0 Disease modification (D) 2014-04-29 2014-04-29 Trial Unspecified 02 N 220023646 TRIAL
220020460 220006233 1.72 79.4 Curative (C) 2016-07-11 2016-07-11 Trial Unspecified Y N 220023647 TRIAL
220020461 220006238 1.62 null Curative (C) 2014-03-17 2014-03-17 AML 19 TRIAL N N 220023671 AML19 TRIAL
220020462 220006241 1.77 59.6 Curative (C) null 2016-12-29 AML 19 TRIAL N N 220023676 AML19 TRIAL
220020463 220006243 1.78 0 Curative (C) 2014-02-21 2014-04-16 Trial Unspecified Y null 220023681 TRIAL
220020464 220006247 1.66 56 Adjuvant (A) 2016-11-21 2016-11-21 AML 19 TRIAL N N 220023701 AML19 TRIAL
220020465 220006257 1.84 100 null 2013-08-29 2013-08-29 AML 19 TRIAL 01 N 220023737 AML19 TRIAL
220020466 220019492 1.63 49.5 Curative (C) 2014-07-18 2014-08-26 Trial Unspecified Y N 220023739 TRIAL
220020468 220006263 1.76 106 Curative (C) 2015-07-20 2015-07-24 AML 19 TRIAL N N 220023759 AML19 TRIAL
220020469 220006268 null 57.6 Disease modification (D) 2017-03-29 2017-03-29 Trial Unspecified 02 N 220023778 TRIAL
220020470 220006271 null 66.6 Curative (C) 2013-09-14 2013-09-14 AML 19 TRIAL Y null 220023793 AML19 TRIAL
220020471 220006277 1.59 69.2 Curative (C) 2014-10-29 2015-01-01 Trial Unspecified Y N 220023811 TRIAL
220020472 220013387 0 88.9 Curative (C) 2017-05-03 2017-09-28 AML 19 TRIAL Y N 220023821 AML19 TRIAL
220020474 220006288 1.76 66 Disease modification (D) 2014-12-10 2014-12-12 Hydroxycarbamide N N 220023833 HYDROXYCARBAMIDE
220020475 220013396 1.65 0 Palliative (P) 2018-10-09 2018-10-09 Hydroxycarbamide 99 N 220023866 HYDROXYCARBAMIDE
220020476 220006300 0 null Curative (C) 2017-11-05 2017-11-09 Hydroxycarbamide N N 220023873 HYDROXYCARBAMIDE
220020477 220006301 null 8.8 Curative (C) null 2017-07-19 FLUDARABINE + THIOTEPA + TREOSULFAN N N 220023877 NOT MATCHED
220020478 220006308 null null Palliative (P) null 2014-01-06 CYTARABINE 2 N 220023897 CYTARABINE
220020479 220017327 1.51 65.1 Curative (C) 2017-01-25 2017-01-25 AML MyeChild 01 FLA-Idarubicin N N 220023938 NOT MATCHED
220020480 220006322 0 81 Disease modification (D) 2017-08-15 2017-08-22 CYTARABINE N N 220023967 CYTARABINE
220020481 220006327 1.51 70.3 Palliative (P) 2019-08-12 2019-08-13 Cytarabine Low Dose N N 220023982 CYTARABINE
220020482 220013421 1.76 null Curative (C) 2016-08-22 2016-09-30 null 2 N 220024000 NOT MATCHED
220020483 220006331 null 74.5 Disease modification (D) 2018-03-31 2018-04-05 Cytarabine low (10to20mg/m2) IV/SC N N 220024003 CYTARABINE
220020484 220013424 1.83 null Disease modification (D) 2018-04-26 2018-04-26 Hydroxycarbamide 2 N 220024004 HYDROXYCARBAMIDE
220020485 220013426 1.66 null Disease modification (D) 2017-11-27 2017-11-27 Cytarabine low (10to20mg/m2) IV/SC N N 220024041 CYTARABINE
220020486 220019507 1.65 41 Disease modification (D) null 2015-02-22 null 2 N 220024091 NOT MATCHED
220020487 220006339 0 33.4 Curative (C) 2016-09-16 2016-10-13 AML Relapsed FLA - DaunoXome 2 N 220024098 NOT MATCHED
220020488 220006343 1.31 76 Curative (C) 2013-10-12 2014-01-08 Cytarabine Low Dose N N 220024100 CYTARABINE
220020490 220017348 1.74 87.1 Curative (C) 2013-01-03 2017-09-25 Cytarabine Intrathecal (any age) null null 220024163 CYTARABINE
220020491 220006356 1.87 29.4 Palliative (P) 2013-12-10 2014-03-11 null 02 N 220024182 NOT MATCHED
220020492 220006364 null 97 Palliative (P) 2017-07-02 2017-07-03 CYTARABINE 02 N 220024207 CYTARABINE
220020493 220006367 1.8 84.4 Disease modification (D) 2015-05-14 2015-05-14 CYTARABINE N N 220024225 CYTARABINE
220020494 220006369 1.62 66 Palliative (P) null 2014-07-28 Hydroxycarbamide N N 220024229 HYDROXYCARBAMIDE
220020495 220006377 0 108 null 2015-09-05 2016-06-17 Hydroxycarbamide 02 N 220024262 HYDROXYCARBAMIDE
220020496 220006385 null 104 Palliative (P) 2014-10-09 2014-10-23 Cytarabine Low Dose null N 220024302 CYTARABINE
220020497 220006387 null null Disease modification (D) 2015-06-24 2015-06-25 Hydroxycarbamide null N 220024304 HYDROXYCARBAMIDE
220020498 220006392 0 null Disease modification (D) 2016-10-15 2017-04-01 Hydroxycarbamide N N 220024319 HYDROXYCARBAMIDE
220020499 220006398 null 73.2 Disease modification (D) 2016-03-16 2016-03-16 Hydroxycarbamide N N 220024325 HYDROXYCARBAMIDE
220020500 220021445 1.48 7.6 Curative (C) 2015-08-09 2015-11-21 AML MyeChild 01 A Mitozantrone/Cytarabine N N 220024326 NOT MATCHED
220020501 220006406 null 5.4 Curative (C) 2015-06-04 2015-07-17 CYTARABINE + ETOPOSIDE + MITOXANTRONE 2 N 220024353 NOT MATCHED
220020502 220017362 null 88.6 Curative (C) 2015-06-10 2015-06-10 Cytarabine Low Dose Y N 220024357 CYTARABINE
220020503 220006413 0 null Curative (C) 2018-01-10 2018-02-14 Cytarabine low (10to20mg/m2) IV/SC 2 N 220024371 CYTARABINE
220020505 220006421 null 9.8 Curative (C) 2018-01-15 2018-01-15 null null null 220024410 NOT MATCHED
220020506 220013486 1.85 null Curative (C) 2014-03-17 2014-03-17 Hydroxycarbamide N null 220024416 HYDROXYCARBAMIDE
220020507 220006426 1.54 null Curative (C) 2018-09-24 2018-12-11 CYTARABINE N N 220024421 CYTARABINE